The effects of psychostimulants on the cognitive results and behaviour of children with the combined subtype of attention deficit with hyperactivity;Efectos de los psicoestimulantes en el desempeño cognitivo y conductual de los niños con déficit de atención e hiperactividad subtipo combinado

Revista de Neurologia

Volumn 35, Issue 1, 2002, Pages 17-24

  Mulas, Fernando ^a,b,c   Rosello B ^a   Morant, A ^a   Hernandez S ^b   Pitarch, I ^a,b  

^a HOSPITAL INFANTIL LA FE   (Spain)

^b Inst Valenciano de Neurol Pediat   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Attention deficit with hyperactivity; Behavioural function; Cognitive function; Combined subtype; Methylphenidate

Indexed keywords

METHYLPHENIDATE; PSYCHOSTIMULANT AGENT;

AGGRESSION; ANTISOCIAL BEHAVIOR; ARITHMETIC; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; CHILD; CHILD BEHAVIOR; CLINICAL ARTICLE; COGNITIVE DEFECT; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HYPERACTIVITY; IMPULSIVENESS; LEARNING DISORDER; NEUROPSYCHOLOGICAL TEST; PARENT; PATIENT REFERRAL; PEDIATRICIAN; PSYCHOLOGIST; STATISTICAL SIGNIFICANCE; TEACHER;

EID: 0036663429     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3501.2002212     Document Type: Conference Paper

References (27)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4 Ed. Washington DC: American Psychiatric Association; 1994.
2. Gaub M, Carlson CL. Behavioral characteristics of DSM-IV ADHD subtypes in a school-based population. J Abnorm Child Psychol 1997; 25: 103-11.
3. McBurnett K, Pfiffner LJ, Swanson JM, Ortollini YL, Yamm L. Clinical correlates of children retrospectively classified by DSM-IV attention deficit/hyperactivity disorder subtypes: Contrast with fields trials impairment patterns. Paper presented at the International Conference on Research and Practice in ADHD. Jerusalem, Israel; 1995.
4. Hinshaw SP, Melnick S. Self-management therapies and attention-deficit hyperactivity disorder. Reinforced self-evaluation and anger control interventions. Behav Modific 1992; 16: 253-73.
5. Nolan EE, Volpe RJ, Gadow KD, Sprafkin J. Developmental, gender, and comorbidity differences in clinically referred children with ADHD. J Emot Behav Disord 1999; 7: 11-20.
6. Clarkin JF, Kendall P. Comorbidity and treatment planning: Summary and future directions. J Consult Clin Psychol 1992; 60: 904-8.
7. Spencer T, Biederman J, Wilens T, Harding BA, Donnell BA, Griffin BA. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 1996; 35: 409-32.
8. Wolraich ML, Lindgreen S, Stromquist A, Milich R, Davis C, Watson D. Stimulant medication use by primary care physicians in the treatment of attention-deficit-hyperactivity disorders. Pediatrics 1990; 86: 95-101.
9. Safer DJ, Kraeger JM. A survey of medication treatment hyperactive/inattentive students. J Am Med Assoc 1988; 260: 2256-8.
10. Zito JM, Safer DJ, DosReis S, Magder LS, Gardner JF, Zarin DA. Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder. Pediatr Clin N Am 1999; 46: 945-63.
11. Hoagwood K, Kelleher KJ, Feil M, Comer D. Treatment services for children with ADHD: A national perspective. J Am Acad Child Adolesc Psychiatry 2000; 39: 198-206.
12. Reitman D, Hupp SDA, O'Callaghan PM, Gulley P, Northup J. The influence of a token economy and methylphenidate on attentive and disruptive behavior during sports with ADHD-diagnosed children. Behav Modific 2001; 25: 305-23.
13. Klein R, Abikoff H, Klass E, Ganales D, Seese L, Pollack S. Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Archiv Gen Psychiatry 1997; 54: 1073-80.
14. Smith BDH, Pelham WE, Gnagy E, Yudell R. Equivalent effects of stimulant treatment for attention deficit hyperactivity disorder during childhood and adolescence. J Am Acad Child Adolesc Psychiatry 1998; 37: 314-21.
15. Weschler D. Escala de Inteligencia para Niños Revisada. Madrid: TEA; 1993.
16. Rudel RG, Denkla MB, Broman N. Rapid silent response to repeated target symbols by dyslexic and non-dyslexic children. Brain Lang 1978; 6: 52-62.
17. Kirk SA, McCarthy JJ, Kirk WD. Test de Illinois de Aptitudes Psicolingüisticas. Madrid: TEA; 1986.
18. Kagan J, Rosman B, Day D, Albert J, Phillips W. Information processing in the child significance of analytic and reflective attitudes. J Psychol Monogr 1964; I: 37.
19. Golden CJ. Stroop. Test de Colores y Palabras. Madrid: TEA; 1994.
20. Rey A. Figura de Rey. Test de Copia de Una Figura Compleja. 6 Ed. Madrid: TEA; 1994.
21. Witkins HA, Oltman PK. Test de Figuras Enmascaradas. Madrid: Tea; 1982.
22. Conners CK. Rating scales for use in drug studies with children (Special issue). Psychopharmacol Bull 1973; 24-84.
23. Loney J, Milich R. Hyperactivity, inattention and aggression in clinical practice. In Wolraich M, Routh DK, eds. Advances in behavioral pediatrics. Vol. 2. Greenwich, CT: JAI Press; 1982. p. 113-47.
24. Miranda A, Llácer MD, Peiró R, Martorell MC, Silva F. Inventario de problemas en la escuela(IPE). In Silva F, Martorell MC, eds. EPIJ. Evaluación de la Personalidad Infantil y Juvenil. Vol. 1. Madrid: MEPSA; 1993.
25. Greenhill LL, Halperin JM, Abikoff H. Stimulant medications. J Am Acad Child Adolesc Psychiatry 1999; 38: 503-12.
26. Miranda A, Pastor JC, Roselló MB, Mulas F. Eficacia de las intervenciones farmacológicas en el tratamiento de la hiperactividad. Psicothema 1996; 8: 89-105.
27. Spencer T, Biederman J, Wilens T, Harding BA, Donnell BA, Griffin BA. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 1996; 35: 409-432.